Push Dr. Ltd.

Push Dr. Ltd.

Push Dr. Ltd.

Overview
Date Founded

2013

Headquarters

Arkwright House,Parsonage Gardens,Manchester, Greater Manchester M3 2LF

Type of Company

Private

Industries

Hospitals & Patient Services
Holding Companies

Company Description

Push Dr. Ltd. provides NHS-commissioned online service connecting patients with a network. The company was founded in 2013 by Eren Ozagir and is headquartered West Midlands, the United Kingdom.

Executives & Employees

Co-Founder

Chief Executive Officer

Chief Medical Officer

Board of Directors

Professional at Tritax Big Box Reit Plc

Venture Partner at Draper Esprit (Private Equity)

Co-Founder at Push Dr. Ltd.

Paths to Push Dr. Ltd.
Potential Connections via
Relationship Science
You
Push Dr. Ltd.
Investors
Details Hidden

Accelerated Digital Ventures Provide Financing for seed, venture and growth funding. The firm also makes co-Investment. The firm focus in the fields of technology sector across the globe.

Details Hidden

Oxford Capital Group's investment activities focus on operationally intensive forms of real estate with the majority of the firm's activities devoted to the lodging/hospitality/leisure sector and senior housing. The firm also has invested selectively in the other major real estate asset classes. In their corporate private equity transactions, Oxford Capital Group focuses on quick service restaurants, consumer retail, select healthcare transactions and financial services, including banking. Oxford Capital is usually the lead sponsor in their transactions; however, in certain situations they may act as a co-lead. The firm's principals frequently take active roles in their investments and/or companies through a board seat and in select situations through an active executive role.

Details Hidden

Seventure is an early-stage private equity investor with a long-term investment horizon. They also invest seed capital. The firm invests in Europe with a strong focus on French start-ups in sectors including information and communication technology as well as biotechnology. They participate in early rounds of financing and stay invested until the company reaches maturity. The firm actively fosters the growth of their portfolio companies. Exit strategies include IPOs and trade sales.The firm sources investments through their network of contacts within public French research entities such as INRIA, INSERM and CNRS as well as in corporations, universities and innovation agencies including OSEO-ANVAR.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Push Dr. Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Push Dr. Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Push Dr. Ltd..